Jeyaraman Jeyakanthan​

Dr. Jeyaraman Jeyakanthan​


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HMHideaki Mizuno
Hideaki Mizuno
TMTapas Kumar Mal
Tapas Kumar Mal
MWMarkus Wälchli
Markus Wälchli
AKAkihiro Kikuchi
Akihiro Kikuchi
TFTakashi Fukano
Takashi Fukano
AMAtsushi Miyawaki
Atsushi Miyawaki
The structural basis for the photochromism in the fluorescent protein Dronpa is poorly understood, because the crystal structures of the bright state of the protein did not provide an answer to the mechanism of the photochromism, and structural determination of the dark state has been elusive. We performed NMR analyses of Dronpa in solution at ambient temperatures to find structural flexibility of the protein in the dark state. Light-induced changes in interactions between the chromophore and β-barrel are responsible for switching between the two states. In the bright state, the apex of the chromophore tethers to the barrel by a hydrogen bond, and an imidazole ring protruding from the barrel stabilizes the plane of the chromophore. These interactions are disrupted by strong illumination with blue light, and the chromophore, together with a part of the β-barrel, becomes flexible, leading to a nonradiative decay process.

1 June 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
PBPandi Boomi
Pandi Boomi
RGR.M. Ganesan
R.M. Ganesan
GPG. Poorani
G. Poorani
HPH. Gurumallesh Prabu
H. Gurumallesh Prabu
SRS. Ravikumar
S. Ravikumar
JJJeyaraman Jeyakanthan​
Jeyaraman Jeyakanthan​

16 June 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Open access
NMNatarjan Arul Murugan
Natarjan Arul Murugan
CPChitra Jeyaraj Pandian
Chitra Jeyaraj Pandian
JJJeyaraman Jeyakanthan​
Jeyaraman Jeyakanthan​
The outbreak due to SARS-CoV-2 (or Covid-19) is spreading alarmingly and number of deaths due to infection is aggressively increasing every day. Due to the rapid human to human transmission of Covid-19, we are in need to find a potent drug at the earliest by ruling-out the traditional time-consuming approach of drug development. This is only possible if we use reliable computational approaches for screening compounds from chemical space or by drug repurposing or by finding the phytochemicals and nutraceuticals from plants as they can be immediately used without the need for carrying out drug-trials to test safety and efficacy. A number of plant products were routinely suggested as drugs in traditional Indian and Chinese medicine. Here using molecular docking approach, and combined molecular dynamics and MM-GBSA based free energy calculations approach, we study the potency of the four selected phytochemicals namely andrographolide (AGP1), 14-deoxy 11,12-didehydro andrographolide (AGP2), neoandrographolide (AGP3) and 14-deoxy andrographolide (AGP4) from A. paniculata plant against the four key targets including three non-structural proteins (3 L main protease (3CLpro), Papain-like proteinase (PLpro) and RNA-directed RNA polymerase (RdRp)) and a structural protein (spike protein (S)) of the virus which are responsible for replication, transcription and host cell recognition. The therapeutic potential of the selected phytochemicals against Covid-19 were also evaluated in comparison with a few commercially available drugs. The binding free energy data suggest that AGP3 could be used as a cost-effective drug-analog for treating covid-19 infection in developing countries. Communicated by Ramaswamy H. Sarma

23 October 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MRMathangi Ravi
Mathangi Ravi
SGSilpa Gampala
Silpa Gampala
GBGanga Baskar
Ganga Baskar
SPSurabhi Rohan Prasad
Surabhi Rohan Prasad
SRSwetha Raghavan
Swetha Raghavan
VGVenkatraman Ganesh
Venkatraman Ganesh
Triple-negative breast cancers represent an important clinical challenge, as these cancers do not respond to conventional endocrine therapies or other available targeted agents. Phycocyanin (PC), a natural, water soluble and non-toxic molecule is shown to have potent anti-cancer property. In this study, we determined the efficacy of PC as an anti-neoplastic agent in vitro on a series of breast cancer cell lines. We studied effects of PC in inducing DNA damage and apoptosis through western blot and qPCR. Also, anti-metastatic and anti-angiogenic properties were studied by classic wound healing and vasculogenic mimicry assays. We found that triple negative MDA-MB-231 cells were most sensitive to PC (IC50 : 5.98 ± 0.95 μM) as compared to other cells. They also showed decreased cell proliferation and reduced colony formation ability upon treatment with PC. Profile of Cell cycle analysis showed that PC caused G1 arrest which could be attributed to decreased mRNA levels of Cyclin E and CDK-2 and increased p21 levels. Mechanistic studies revealed that PC induced apoptosis as evident by increase in percentage of annexin positive cells, increase in γ-H2AX levels, and by changing the Bcl-2/Bax ratio followed by release of cytochrome C and increased Caspase 9 levels. MDA MB 231 cells treated with PC resulted in decreased cell migration and increased cell adhesive property and also showed anti-angiogenic effects. We also observed that PC suppressed cyclooxygenase-2 (COX-2) expression and prostaglandin E(2) production. All these biological effects of phycocyanin on MDA MB 231 cells could be attributed to decreased MAPK signaling pathway. We also observed that PC is non-toxic to non-malignant cells, platelets and RBC’s. Taken together, these findings demonstrate, for the first time, that PC may be a promising anti-neoplastic agent for treatment of triple negative breast cancers.

29 March 2011 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
KSKh. Dhanachandra Singh
Kh. Dhanachandra Singh
Kirubakaran PalaniKirubakaran Palani
Kirubakaran Palani
SNShanthi Nagarajan
Shanthi Nagarajan
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
KMKarthikeyan Muthusamy
Karthikeyan Muthusamy
JJJeyaraman Jeyakanthan​
Jeyaraman Jeyakanthan​

13 March 2019 in Journal of Cluster Science
Verified
Journal Article
Closed access
PDF file
PBPandi Boomi
Pandi Boomi
GPGurumallesh Prabu Poorani
Gurumallesh Prabu Poorani
SPSubramaniyan Palanisamy
Subramaniyan Palanisamy
SAMAYANAN SELVAMSAMAYANAN SELVAM
SAMAYANAN SELVAM
GRGanesan Ramanathan
Ganesan Ramanathan
Saravanan MuthupandianSaravanan Muthupandian
Saravanan Muthupandian